Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2024

Nov 7, 2024

30291_dirs_2024-11-07_5a42e1cb-afa6-4adf-9b31-747b34a122f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2024-11-05

Reporting Person: ALEXANDER SUSAN H (EVP Chief Legal Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-05 Common Stock G 20082 Disposed 31601 Direct
2024-11-05 Common Stock G 20082 Acquired 20082 Indirect

Footnotes

F1: This transaction involved a gift of securities by the reporting person to an irrevocable trust for the benefit of the reporting person's children on November 5, 2024. The reporting person's spouse is the trustee of the trust.